United States-based Apotex Corp announced on Tuesday that it has launched its Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxane, in the United States.
The product is indicated for the treatment of metastatic breast cancer, non-small cell lung cancer and adenocarcinoma of the pancreas.
Peter Hardwick, Apotex Corp president, said, 'We are proud to provide Americans with a generic option of this important medication. This launch provides patients with a high-quality medication at an affordable price.'
Upsher-Smith launches Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%
Torrent Pharma starts shipping generic Keveyis (dichlorphenamide), 50mg tablets in US
Upsher-Smith Laboratories introduces Fluphenazine Hydrochloride Tablets
American Regent launches sulphite-free Epinephrine Injection
Teva and Natco Launch Additional Strengths for the Generic Version of Revlimid in the US
Accord Healthcare adds Teriflunomide to oral medications range